ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

SCLP Scancell Holdings Plc

9.875
0.00 (0.00%)
Last Updated: 08:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Scancell Holdings Plc LSE:SCLP London Ordinary Share GB00B63D3314 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 9.875 9.50 10.25 9.875 9.875 9.88 160,851 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 5.27M -11.94M -0.0129 -7.65 91.58M
Scancell Holdings Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SCLP. The last closing price for Scancell was 9.88p. Over the last year, Scancell shares have traded in a share price range of 7.65p to 18.125p.

Scancell currently has 927,819,977 shares in issue. The market capitalisation of Scancell is £91.58 million. Scancell has a price to earnings ratio (PE ratio) of -7.65.

Scancell Share Discussion Threads

Showing 11801 to 11823 of 66525 messages
Chat Pages: Latest  477  476  475  474  473  472  471  470  469  468  467  466  Older
DateSubjectAuthorDiscuss
19/9/2017
10:31
Will they need another placing or have they got cash to survive until hopefully this gets approval in a couple of years time?
montyhedge
19/9/2017
10:30
panama7 - RG has held his hands up and admitted that they made a mistake by not going to the US sooner than they did (BioCap Conference) but he cannot single handedly alter the sentiment surrounding vaccines throughout an entire Industry. He can and has knocked on doors and kept the Science, particularly Moditope, advancing with LD's tweaking (adjuvant linker technology) etc.

So to the contrary you don't appear to be taking any of it into account but hey - have it your way :

"intransigent /ɪnˈtransɪdʒ(ə)nt/

synonyms: uncompromising, inflexible, unbending, unyielding, unshakeable, unwavering, resolute, unpersuadable, unmalleable, unaccommodating, uncooperative, stubborn, obstinate, obdurate, pig-headed, bull-headed, single-minded, iron-willed, hard-line, hard and fast, diehard, immovable, unrelenting, inexorable, inveterate, rigid, tough, firm, determined, adamant, tenacious; More
informalstiff-necked;

informalbloody-minded; informalbalky, badass; rareindurate

"his intransigent attitude led to the quarrels with his friends"

You've shared some good research in the past - I hope you afford yourself the chance of asking RG at the AGM for a full and frank explanation surrounding the place vaccines has had within the Oncology sector over the last few years - as clearly you choose to ignore everything & everyone else.

gooosed
19/9/2017
10:07
Goosed, so taking all that into account the best Goodfellow can do is raise funds at their lowest value for 5 years a 60% discount to the raising at 22p, to do the trial in the first place. I can only assume the IP lost 50% of it's value in those 4 years.
panama7
19/9/2017
09:52
panama7 - More than happy to agree re your right to free speech.

However, the recent wholesale media commentary & evidence (from numerous sources) supports Goodfellows comments re the return of sentiment surrounding vaccines. Particularly when voiced by Oncology MD's, researchers and industry bodies.

All serves to highlight your comments as being intransigent (at best) and bordering on the obsessive.

gooosed
19/9/2017
09:12
Goosed, we have every right to lambast Goodfellow, he has just raised funds at the lowest share price for 5 years at a time when vaccines are in vogue. He has spent the last 5 years decimating the share price left virtually every LTH sitting on losses and failed to deliver on all his statements and rhetoric. He has openly encouraged and coerced Chelsea into continually buying the share stating that everything is on track and going to plan when nothing could be further from the truth. We now have the SCIB1 vaccine sitting on the shelf doing nothing eating into it's use by date because the trials are running significantly late. He is simply out of his depth and is quite frankly his contempt and lack of respect for share holders points him out as a very nasty little man.
panama7
18/9/2017
21:55
chelsea35 - yes and a reminder perhaps to those that continually lambast Richard Goodfellow :

“We couldn’t get any big pharmaceutical company to even talk to us about a cancer vaccine” while he was at the institute, Heery said, but now partnerships and deals involving vaccine-making biotechs are common.

“I don’t think that’s a coincidence,” he said. “I think they’re reading the tea leaves.”

Not sure about "common" but with the Moditope Patent - who knows ;-)

gooosed
18/9/2017
20:08
Good to hear so soon after Bavarian Nordic.
chelsea35
18/9/2017
19:07
"May being a month = can be a month .."
May be, but it also 'CAN' fly.!!!

the real lozan
18/9/2017
18:04
Agree with that Lozan, not doubting we will get it at all, just the timelines. Odd day today, the bid fell from 12.8 to 12.725, and the ask 13.24 to 12.895 in one tick down.
Must be a hefty sell to come, but MMs still wanting shares? Not so easy to read on a volume of 248!!!

chelsea35
18/9/2017
15:46
One could say = "The RISKS here are 'PATENTLY' clear"
the real lozan
18/9/2017
15:44
May being a month = can be a month ...
inanaco
18/9/2017
15:38
????????????????????????? No point debating "may" ... as that can also mean "can"

Surely you mean " no point debating "may" ... as that may also mean " can ".

tosh123
18/9/2017
15:35
I don't need to debate the meaning of " can ", the Oxford dictionary already does that most eloquently.
tosh123
18/9/2017
15:15
so Tosh and Herbie are One .... LOL
inanaco
18/9/2017
15:14
Gazza

No point debating "may" ... as that can also mean "can" .. according to Tosh

so that's best left with Tosh to explain

I see it as may be allowable once the Patent is fully processed as this is not the area of dispute.

inanaco
18/9/2017
15:10
Wanderer... that made me laugh out loud... great post.
Sums up in a couple of lines, just how idiotic a certain persons posts are.

tosh123
18/9/2017
15:09
Gazza, once again, you are 100% correct, and therefore by definition, the risks are " investment risks " NOT personal risks.
The village idiot has ONCE AGAIN, painted himself into a corner and destroyed his own flawed argument, its like taking candy from a baby. Still, at least he clearly now accepts that his statement is totally misleading and WRONG.

tosh123
18/9/2017
15:07
I wonder where Legal and General have filed these sharesHigh RiskModerate RiskLow Risk or of courseNo RiskI know where my tenner lies lol
wanderer1210_0
18/9/2017
15:01
Gazza, Its already priced in ... the share knows about the patent today ... its been in an RNS ..
inanaco
18/9/2017
14:59
Drdobson and Tosh - are you related? Your posting style is very similar.
bermudashorts
18/9/2017
14:59
Tosh who are you preaching to ?? Herbie ?
inanaco
18/9/2017
14:58
Tosh,
As Inanaco quotes the patent office "MAY be allowable".

When you do a risk assessment you take into account both the likelyhood of the risk and the CONSEQUENCES. As far the Moditope patent goes, even if the likelyhood of being rejected was low, the consequences would be catastrophic as far as the share price goes - ignore this at your peril. AIMO of course.

gazza
18/9/2017
14:56
nice simple post ....

I am sure Legal and General have more advanced investment managers, Than teams of Mr W's ... with gambling habits

inanaco
Chat Pages: Latest  477  476  475  474  473  472  471  470  469  468  467  466  Older

Your Recent History

Delayed Upgrade Clock